{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:04:53Z","timestamp":1789207493741,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T00:00:00Z","timestamp":1471910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","award":["HPF-2013-459"],"award-info":[{"award-number":["HPF-2013-459"]}],"id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00592-016-0890-9","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T09:32:02Z","timestamp":1471944722000},"page":"965-972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood"],"prefix":"10.1007","volume":"53","author":[{"given":"S.","family":"Bacon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Kyithar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Condron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Vizzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"issue":"Suppl 1","key":"890_CR1","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.2337\/diabetes.50.2007.S94","volume":"50","author":"TM Frayling","year":"2001","unstructured":"Frayling TM, Evans JC, Bulman MP et al (2001) Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50(Suppl 1):S94\u2013S100","journal-title":"Diabetes"},{"key":"890_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00592-015-0786-0","volume":"53","author":"K Antosik","year":"2016","unstructured":"Antosik K, Gnys P, De Franco E et al (2016) Single patient in GCK-MODY family successfully re-diagnosed into GCK-PNDM through targeted next-generation sequencing technology. Acta Diabetol 53:337\u2013338","journal-title":"Acta Diabetol"},{"key":"890_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ymgme.2014.09.007","volume":"113","author":"G Alkorta-Aranburu","year":"2014","unstructured":"Alkorta-Aranburu G, Carmody D, Cheng YW et al (2014) Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Mol Genet Metab 113:315\u2013320","journal-title":"Mol Genet Metab"},{"key":"890_CR4","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s00125-013-2962-5","volume":"56","author":"S Ellard","year":"2013","unstructured":"Ellard S, Lango Allen H, De Franco E et al (2013) Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia 56:1958\u20131963","journal-title":"Diabetologia"},{"key":"890_CR5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.diabet.2011.04.002","volume":"37","author":"MP Kyithar","year":"2011","unstructured":"Kyithar MP, Bacon S, Pannu KK et al (2011) Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications. Diabetes Metab 37:512\u2013519","journal-title":"Diabetes Metab"},{"key":"890_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0778","volume":"4","author":"R Murphy","year":"2008","unstructured":"Murphy R, Ellard S, Hattersley AT (2008) Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 4:200\u2013213","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"890_CR7","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1007\/s00125-010-1799-4","volume":"53","author":"BM Shields","year":"2010","unstructured":"Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504\u20132508","journal-title":"Diabetologia"},{"key":"890_CR8","doi-asserted-by":"publisher","unstructured":"Carmody D, Naylor RN, Bell CD et al (2016) GCK-MODY in the US National monogenic diabetes registry: frequently misdiagnosed and unnecessarily treated. Acta Diabetol. doi: 10.1007\/s00592-016-0859-8","DOI":"10.1007\/s00592-016-0859-8"},{"key":"890_CR9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00592-014-0567-1","volume":"51","author":"W Fendler","year":"2014","unstructured":"Fendler W, Rizzo M, Borowiec M et al (2014) Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level. Acta Diabetol 51:625\u2013632","journal-title":"Acta Diabetol"},{"key":"890_CR10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","volume":"362","author":"ER Pearson","year":"2003","unstructured":"Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT (2003) Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362:1275\u20131281","journal-title":"Lancet"},{"key":"890_CR11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/dme.12992","volume":"33","author":"S Bacon","year":"2015","unstructured":"Bacon S, Kyithar MP, Rizvi SR et al (2015) Successful maintenance on sulfonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort. Diabetic Med 33:976\u2013984","journal-title":"Diabetic Med"},{"key":"890_CR12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jama.2013.283980","volume":"311","author":"AM Steele","year":"2014","unstructured":"Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT (2014) Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 311:279\u2013286","journal-title":"JAMA"},{"issue":"236","key":"890_CR13","first-page":"e231","volume":"213","author":"S Bacon","year":"2015","unstructured":"Bacon S, Schmid J, McCarthy A et al (2015) The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young. Am J Obstet Gynecol 213(236):e231\u2013e237","journal-title":"Am J Obstet Gynecol"},{"key":"890_CR14","doi-asserted-by":"publisher","unstructured":"Bitterman O, Iafusco D, Torcia F, Tinto N, Napoli A (2016) A dizygotic twin pregnancy in a MODY 3-affected woman. Acta Diabetol. doi: 10.1007\/s00592-016-0848-y","DOI":"10.1007\/s00592-016-0848-y"},{"key":"890_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2337\/diab.43.1.40","volume":"43","author":"WH Herman","year":"1994","unstructured":"Herman WH, Fajans SS, Ortiz FJ et al (1994) Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43:40\u201346","journal-title":"Diabetes"},{"key":"890_CR16","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s001250051558","volume":"43","author":"D Tripathy","year":"2000","unstructured":"Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L (2000) Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia 43:1476\u20131483","journal-title":"Diabetologia"},{"key":"890_CR17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2337\/diacare.16.9.1254","volume":"16","author":"SS Fajans","year":"1993","unstructured":"Fajans SS, Brown MB (1993) Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young. Diabetes Care 16:1254\u20131261","journal-title":"Diabetes Care"},{"key":"890_CR18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1172\/JCI200522365","volume":"115","author":"RK Gupta","year":"2005","unstructured":"Gupta RK, Vatamaniuk MZ, Lee CS et al (2005) The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J Clin Investig 115:1006\u20131015","journal-title":"J Clin Investig"},{"key":"890_CR19","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1371\/journal.pmed.0040118","volume":"4","author":"ER Pearson","year":"2007","unstructured":"Pearson ER, Boj SF, Steele AM et al (2007) Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 4:e118","journal-title":"PLoS Med"},{"key":"890_CR20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1530\/EJE-09-0861","volume":"162","author":"SE Flanagan","year":"2010","unstructured":"Flanagan SE, Kapoor RR, Mali G et al (2010) Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol\/Eur Fed Endocr Soc 162:987\u2013992","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"key":"890_CR21","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/db07-1657","volume":"57","author":"RR Kapoor","year":"2008","unstructured":"Kapoor RR, Locke J, Colclough K et al (2008) Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes 57:1659\u20131663","journal-title":"Diabetes"},{"key":"890_CR22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/dme.12259","volume":"31","author":"SM McGlacken-Byrne","year":"2014","unstructured":"McGlacken-Byrne SM, Hawkes CP, Flanagan SE, Ellard S, McDonnell CM, Murphy NP (2014) The evolving course of HNF4A hyperinsulinaemic hypoglycaemia\u2014a case series. Diabetic Med 31:e1\u2013e5","journal-title":"Diabetic Med"},{"key":"890_CR23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","volume":"24","author":"A Mari","year":"2001","unstructured":"Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539\u2013548","journal-title":"Diabetes Care"},{"key":"890_CR24","first-page":"2694","volume":"83","author":"RS Legro","year":"1998","unstructured":"Legro RS, Finegood D, Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694\u20132698","journal-title":"J Clin Endocrinol Metab"},{"key":"890_CR25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00125-001-0770-9","volume":"45","author":"A Stride","year":"2002","unstructured":"Stride A, Vaxillaire M, Tuomi T et al (2002) The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45:427\u2013435","journal-title":"Diabetologia"},{"key":"890_CR26","first-page":"CR9","volume":"17","author":"J Zhou","year":"2011","unstructured":"Zhou J, Li H, Ran X et al (2011) Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit 17:CR9\u2013CR13","journal-title":"Med Sci Monit"},{"key":"890_CR27","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc12-2480","volume":"36","author":"ER Seaquist","year":"2013","unstructured":"Seaquist ER, Anderson J, Childs B et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36:1384\u20131395","journal-title":"Diabetes Care"},{"key":"890_CR28","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1007\/s00125-007-0833-7","volume":"50","author":"SS Fajans","year":"2007","unstructured":"Fajans SS, Bell GI (2007) Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A). Diabetologia 50:2600\u20132601","journal-title":"Diabetologia"},{"key":"890_CR29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1089\/dia.2010.0247","volume":"13","author":"NR Hill","year":"2011","unstructured":"Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR (2011) Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 13:921\u2013928","journal-title":"Diabetes Technol Ther"},{"key":"890_CR30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/dc10-2164","volume":"34","author":"T Aye","year":"2011","unstructured":"Aye T, Reiss AL, Kesler S et al (2011) The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care 34:1458\u20131462","journal-title":"Diabetes Care"},{"key":"890_CR31","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2337\/dc12-0017","volume":"35","author":"T Aye","year":"2012","unstructured":"Aye T, Barnea-Goraly N, Ambler C et al (2012) White matter structural differences in young children with type 1 diabetes: a diffusion tensor imaging study. Diabetes Care 35:2167\u20132173","journal-title":"Diabetes Care"},{"key":"890_CR32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0883073809341667","volume":"25","author":"G Shehata","year":"2010","unstructured":"Shehata G, Eltayeb A (2010) Cognitive function and event-related potentials in children with type 1 diabetes mellitus. J Child Neurol 25:469\u2013474","journal-title":"J Child Neurol"},{"key":"890_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/dc14-1385","volume":"38","author":"A Lin","year":"2015","unstructured":"Lin A, Northam EA, Werther GA, Cameron FJ (2015) Risk factors for decline in IQ in youth with type 1 diabetes over the 12\u00a0years from diagnosis\/illness onset. Diabetes Care 38:236\u2013242","journal-title":"Diabetes Care"},{"key":"890_CR34","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/dme.12369","volume":"31","author":"VB Arya","year":"2014","unstructured":"Arya VB, Rahman S, Senniappan S, Flanagan SE, Ellard S, Hussain K (2014) HNF4A mutation: switch from hyperinsulinaemic hypoglycaemia to maturity-onset diabetes of the young, and incretin response. Diabetic Med 31:e11\u2013e15","journal-title":"Diabetic Med"},{"key":"890_CR35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diab.44.6.699","volume":"44","author":"MM Byrne","year":"1995","unstructured":"Byrne MM, Sturis J, Fajans SS et al (1995) Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 44:699\u2013704","journal-title":"Diabetes"},{"key":"890_CR36","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/diab.46.11.1749","volume":"46","author":"WH Herman","year":"1997","unstructured":"Herman WH, Fajans SS, Smith MJ, Polonsky KS, Bell GI, Halter JB (1997) Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha\/MODY1 gene. Diabetes 46:1749\u20131754","journal-title":"Diabetes"},{"key":"890_CR37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2337\/diabetes.49.6.961","volume":"49","author":"LL Ilag","year":"2000","unstructured":"Ilag LL, Tabaei BP, Herman WH et al (2000) Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha\/MODY1 gene. Diabetes 49:961\u2013968","journal-title":"Diabetes"},{"key":"890_CR38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","volume":"21","author":"C Bonner","year":"2015","unstructured":"Bonner C, Kerr-Conte J, Gmyr V et al (2015) Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med 21:512\u2013517","journal-title":"Nat Med"},{"key":"890_CR39","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1530\/JME-15-0016","volume":"54","author":"SA Rahman","year":"2015","unstructured":"Rahman SA, Nessa A, Hussain K (2015) Molecular mechanisms of congenital hyperinsulinism. J Mol Endocrinol 54:R119\u2013R129","journal-title":"J Mol Endocrinol"},{"issue":"Suppl 1","key":"890_CR40","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.2337\/diabetes.53.2007.S71","volume":"53","author":"MC Sugden","year":"2004","unstructured":"Sugden MC, Holness MJ (2004) Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 53(Suppl 1):S71\u2013S81","journal-title":"Diabetes"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-016-0890-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:12:50Z","timestamp":1498324370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-016-0890-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s00592-016-0890-9","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,23]]}}}